Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
about
Gut dysfunction in Parkinson's diseaseReview of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'Monitoring of serum prolactin in pediatric patients with cystic fibrosis who are receiving domperidone.Pharmacological treatment of Parkinson's disease.Effects of dietary factors on levodopa pharmacokinetics.Drug treatment of non-motor symptoms in Parkinson's disease.Review: management of Parkinson's disease.Development and validation of UPLC-MS/MS method for determination of domperidone in human plasma and its pharmacokinetic application.Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).Domperidone: review of pharmacology and clinical applications in gastroenterology.Bladder, bowel, and sexual dysfunction in Parkinson's diseaseGastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.Treatment of gastroparesis: a multidisciplinary clinical review.Irregular gastrointestinal drug absorption in Parkinson's disease.Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review.Gastrointestinal features of Parkinson's disease.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.An update on current pharmacotherapy options for dyspepsia.Management of constipation in Parkinson's disease.Emerging drugs for functional dyspepsia.Current advances in treatment of gastroparesis.The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.Parkinson's Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options - A Practise Guide.Unmasking levodopa resistance in Parkinson's disease.Gastroparesis Updates on Pathogenesis and Management.Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease.Light/dark phase-dependent spontaneous activity is maintained in dopamine-deficient mice.Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying.Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.Gastric emptying time and gastric motility in patients with Parkinson's disease.Oral domperidone has no additional effect on chronic functional constipation in children: a randomized clinical trial.Nizatidine ameliorates gastroparesis in Parkinson's disease: a pilot study.A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.Domperidone for Hypotension in Parkinson's Disease: A Systematic Review.Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath testLate (Complicated) Parkinson's DiseaseProfile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
P2860
Q26739037-726EA368-400D-4E51-87B0-0B77B20E114EQ33260251-A347093B-DE7E-4F17-B034-05BBE05E0A37Q33681145-F73382CD-1E06-4C00-B9A5-3837A9FE912FQ34048261-B574B264-D466-4D7A-A9ED-C702F5BE3AC7Q34109657-A5CAE7F3-DA0D-4437-A64C-C8F473F8016FQ34122222-0067651D-EB94-4F14-9C42-5AA11427CA6EQ34332812-E50ECF95-C71F-41AD-9621-E29B6ABE0D26Q34380044-4CBD98C4-58D5-45F2-B00B-54ED13C4CA82Q34504541-9BAF254E-19E4-4A9F-9C1D-D68ADB45D649Q34626516-7365B3CE-7ED5-414E-8CAB-D0A4355BAF3AQ35209869-D1A79EC9-02C6-42C4-8C28-2522F63CAEE9Q35917625-349EA601-D852-4B5A-B79A-ECC9D7FE7F7CQ36428532-78CEF6E0-8835-4452-B22F-2D7D3CA55C8AQ37076343-570E5178-C0C0-4200-BE75-3523F9B2FA61Q37516494-9903CC5F-CAD7-4643-9061-6F3BEC0AA06AQ37697903-C52FF49D-E23D-4A3D-A94A-F7F31A2113A6Q37866126-0EC48D6D-D8A0-4534-AFBF-14A597630B58Q38070888-E7047632-49E9-452C-A92F-77EDCD34ADECQ38115358-A13D22F2-D533-4347-8841-398AE701C65EQ38300388-41F1BC6D-2207-4B82-98BD-3F0D1AD53498Q38342083-F2E94789-0B6A-4671-9B68-66A887E57E08Q38550545-B982D08E-F563-4726-A296-44461E3F1DDFQ38587559-245A88E3-2CFC-49F2-8F7A-6EEFA4209798Q38592741-2B44D894-B7CF-42BB-800F-DFBBA5EC698BQ38901323-3F661AD1-99E4-4C8E-BCAD-285554063559Q39324779-75E0EAF8-E05C-45AB-8857-F16132107B53Q39393248-E5590AEB-E9B8-4469-9B3B-6D75483CE69CQ42379274-E230D4AD-8C2F-4FD8-AC2F-252557C8183DQ43096307-155AF826-D0D0-4141-BDFA-B7BC52544EC7Q43685308-F2BEAEB2-4D17-46E7-8295-A3634360961DQ43827121-E5868099-BEF0-4B4B-9A76-46509FE59F58Q44315944-7AE07F0A-BE8F-4D6C-8639-3046AFEBFA2AQ44634773-6EDEE889-9D77-4E6F-8EE5-004318798805Q48529114-821C4BBC-4D4B-4618-A77F-4E0771A1F777Q50157700-C6EACD98-B75F-4113-9A3F-8182AA3682DDQ52672547-13E639AD-CDC3-423E-BEFA-4AFF95286766Q57279624-5CB9C13C-8F03-45A1-A458-37879E544A13Q58870320-8528E99C-A835-498B-AF80-56C9F4297622Q59125833-474D796C-0EDE-4844-9E52-9A8D5D81BFAE
P2860
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Effect of chronic oral domperi ...... ents with Parkinson's disease.
@ast
Effect of chronic oral domperi ...... ents with Parkinson's disease.
@en
type
label
Effect of chronic oral domperi ...... ents with Parkinson's disease.
@ast
Effect of chronic oral domperi ...... ents with Parkinson's disease.
@en
prefLabel
Effect of chronic oral domperi ...... ents with Parkinson's disease.
@ast
Effect of chronic oral domperi ...... ents with Parkinson's disease.
@en
P2093
P2860
P356
P1433
P1476
Effect of chronic oral domperi ...... ents with Parkinson's disease.
@en
P2093
McCallum RW
Sarosiek I
Shifflett J
P2860
P304
P356
10.1002/MDS.870120618
P407
P577
1997-11-01T00:00:00Z